NYSE · Healthcare · Healthcare Plans · USA
Cigna Group is a large cap company (market value between $10 billion and $200 billion) in the Healthcare Plans industry.
Cigna Group operates as a global health firm through two main divisions: Evernorth Health Services and Cigna Healthcare. Evernorth administers pharmacy programs and specialty care services across the healthcare ecosystem. Cigna Healthcare delivers medical insurance and integrated care solutions to employers and individuals throughout the United States and internationally.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Cigna Group stock.
Undervalued: intrinsic value $660.74 per share, market price $298.50, margin of safety 54.8% (as of 2026-10-19).
Discounting its cash flows at 6.8% (average of 3 methods) values the shares at $660.74; the price of $298.50 is 55% below that value, and 84% of that value comes from beyond year five.
Leak Score: 72/100 on 11 of 12 signals (Clear Leak).
17 more funds hold it; the full list is part of the paid plan.
All 11 Healthcare Plans stocks
CI is undervalued (as of the 2026-10-19 close). Discounting its cash flows at 6.8% (average of 3 methods) values the shares at $660.74; the price of $298.50 is 55% below that value, and 84% of that value comes from beyond year five.
$660.74 per share (as of the 2026-10-19 close), against a market price of $298.50. That is a margin of safety of 54.8%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
The price asks for less growth than the company has already delivered. Repeating its past would be enough. Yearly sales decline the price allows: 11.3%. Yearly sales growth it has sustained: 8.5%.
72 out of 100, which we rate "Clear Leak", on 11 of 12 value investing signals.